Apr 30, 2020
InMed Receives CTA Approval for Second Phase 1 Clinical Trial with INM-755
Mar 27, 2020
Another CanAm EB-5 Investment Project Repays, Marking Total of 41 EB-5 Projects Fully Repaid
Mar 24, 2020
InMed Submits Clinical Trial Application to Evaluate INM-755 in Second Phase 1 Trial
Mar 20, 2020
InMed Provides Update on Operations in Response to the COVID-19 Global Outbreak
Mar 10, 2020
InMed Pharmaceuticals Announces Completed Enrollment in Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects
Jan 27, 2020
Energizer Shareholders Elect New Directors To Board Of Directors
Dec 09, 2019
InMed Receives Clinical Trial Application Approval for INM-755, a Rare Cannabinoid Formulation Under Development for the Treatment of Epidermolysis Bullosa
Nov 05, 2019
InMed Submits Clinical Trial Application to Evaluate INM-755 in Phase 1 Trial
Aug 20, 2019
Elektrobit goes the extra mile for new EV automaker Weltmeister Motor
Aug 07, 2019
Elektrobit chosen as partner by Baidu to enable safe autonomous driving for Apollo
Jul 23, 2019
Energizer Holdings, Inc. To Webcast A Discussion Of Third Quarter Fiscal 2019 Results On August 6, 2019
Apr 11, 2019
Elektrobit provides HMI development platform for Volkswagen
Mar 11, 2019
Investor Alert: Kaplan Fox Announces Investigation Of Eventbrite
Feb 05, 2019
InMed Pharmaceuticals to Report Second Quarter Fiscal 2019 Financial Results and Business Update on February 12, 2019
Jan 22, 2019
TWi Biotechnology Announces Last Patient Enrolled in Phase 2 Proof-of-Concept Study of AC-203 for Treatment of Epidermolysis Bullosa
Jan 07, 2019
Argus, Elektrobit, and NXP provide combined solution to protect connected and automated vehicles
Jan 03, 2019
InMed Pharmaceuticals to Present at Biotech Showcase 2019 on January 9, 2019
Nov 27, 2018
Constant Pharmaceuticals to Initiate Clinical Development of TXA127 for Epidermolysis Bullosa (EB)
Nov 14, 2018
Elektrobit and NXP enable virtual development of ECUs for connected and automated driving
Nov 05, 2018
InMed Pharmaceuticals to Report First Quarter Fiscal 2019 Financial Results and Business Update on November 12, 2018